Fusion of Technologies
Instead of developing commodity products, CCSB focuses on specialty APIs manufactured by a sophisticated fusion of fermentation / synthesis technologies in Taiwan. The products include:
Immunosuppressants: Mycophenolate mofetil, Rapamycin (Sirolimus) and Tacrolimus
Derivative of Rapamycin: Everolimus, Temsirolimus, Zotarolimus and Biolimus
Echinocandin: Caspofungin, Micafungin and AnidulafunginFusion of Technologies